Generate Biomedicines, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
GENB Nasdaq 2836 generatebiomedicines.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Generate Biomedicines, Inc.

Generate Biomedicines Inc. to Participate in Goldman Sachs 47th Annual Global Healthcare Conference - May 28th, 2026 2:05 pm
A Deep Dive Into NVIDIA’s Latest Portfolio Moves - May 19th, 2026 12:05 pm
Generate Biomedicines, Inc. Reports First Quarter 2026 Financial Results and Provides Business Update - May 7th, 2026 4:16 am
H.C. Wainwright Initiates Coverage of Generate Biomedicines (GENB) With a Buy Rating - Apr 19th, 2026 6:11 pm
Generate Biomedicines (GENB) Valuation Check After Recent Share Price Weakness - Mar 8th, 2026 3:11 am
Sector Update: Health Care Stocks Advance Late Afternoon - Feb 27th, 2026 2:02 pm
Generate Biomedicines, Inc. Announces Pricing of Initial Public Offering - Feb 26th, 2026 5:58 pm